MMP2 and osteosarcoma: There were a small number of recent studies reporting prognostic biomarkers for osteosarcoma which were associated with lung metastases and survival such as PLA2G16, MMP-2, CXCR4 and MMP9 [38–40], but none of them showed correlation with response to chemotherapy treatment.